Keith D. Dawkins, EVP, Global Chief Med. Officer at BOSTON SCIENTIFIC CORP (BSX), sold 80,000 shares at $22.15 ($1.8M) on 2016-05-10, disclosed to the SEC on 2016-05-12.
Open-market sale of $1.8M BSX by EVP, Global Chief Med. Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| BSX | SELL | 2013-11-25 | $1.7M | — | Filing → |